• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同时患有溃疡性结肠炎和艰难梭菌的住院患者的结肠切除术率正在上升。

Colectomy Rates Are Increasing Among Inpatients With Concomitant Ulcerative Colitis and Clostridioides difficile.

机构信息

Division of Gastroenterology and Hepatology, University of New Mexico School of Medicine, Albuquerque, NM.

Division of Gastroenterology, University of Arizona College of Medicine.

出版信息

J Clin Gastroenterol. 2021 Sep 1;55(8):709-715. doi: 10.1097/MCG.0000000000001412.

DOI:10.1097/MCG.0000000000001412
PMID:32804686
Abstract

BACKGROUND

Clostridioides difficile infection (CDI) is an important cause of inflammatory bowel disease (IBD) exacerbation and is associated with increased risk of hospitalization, colectomy, and mortality. Previous analysis have reported an increasing rate of CDI and associated mortality in IBD patients. We examined the trends in CDI-associated outcomes in hospitalized patients with Crohn's disease (CD) and ulcerative colitis (UC) over the last decade.

MATERIALS AND METHODS

We used data from the National Inpatient Sample to identify patients hospitalized with both CDI and IBD from 2006 to 2014. Outcomes included in-hospital mortality, partial/total colectomy, hospital length of stay, and charges. Analysis included univariate and multivariate regression analysis.

RESULTS

Between 2006 and 2014, CDI-related hospitalizations increased in both CD (1.6% to 3.2%; P<0.001) and UC (4.9% to 8.6%; P<0.001). CDI-associated mortality in CD and UC patients decreased from 2.4% to 1.2% (P<0.001) and 11.3% to 9.7% (P<0.001), respectively. CDI-associated colectomy rate increased from 4.3% to 8.8% (P<0.001) in UC but decreased from 4.5% to 2.8% (P<0.001) in CD. In multivariable analysis, compared with 2006, there was a nonsignificant decrease in mortality in 2014 in both CD [adjusted odds ratio (AOR) 0.56, 95% confidence interval (CI) 0.25-1.24] and UC (AOR 0.81, 95% CI 0.61-1.07), but a significant increase in colectomy in 2014 only in UC (AOR 2.12, 95% CI 1.46-3.06).

CONCLUSIONS

CDI rates have increased in CD and UC over the last decade. Although there has been a significant increase in colectomies in UC, CDI-associated mortality in CD and UC has not increased over this time.

摘要

背景

艰难梭菌感染(CDI)是炎症性肠病(IBD)恶化的一个重要原因,与住院、结肠切除术和死亡率增加有关。先前的分析报告称,IBD 患者的 CDI 发病率和相关死亡率都在增加。我们研究了过去十年中住院克罗恩病(CD)和溃疡性结肠炎(UC)患者中 CDI 相关结局的趋势。

材料和方法

我们使用国家住院患者样本的数据,从 2006 年至 2014 年期间,确定了同时患有 CDI 和 IBD 的住院患者。研究结果包括住院死亡率、部分/全结肠切除术、住院时间和费用。分析包括单变量和多变量回归分析。

结果

在 2006 年至 2014 年期间,CD 患者中(1.6%至 3.2%;P<0.001)和 UC 患者中(4.9%至 8.6%;P<0.001)CDI 相关住院治疗增加。CD 和 UC 患者的 CDI 相关死亡率从 2.4%降至 1.2%(P<0.001)和 11.3%降至 9.7%(P<0.001)。UC 患者的 CDI 相关结肠切除术率从 4.3%升至 8.8%(P<0.001),但 CD 患者的结肠切除术率从 4.5%降至 2.8%(P<0.001)。多变量分析显示,与 2006 年相比,2014 年 CD 患者的死亡率无显著下降(调整后比值比(AOR)0.56,95%置信区间(CI)0.25-1.24)和 UC 患者(AOR 0.81,95% CI 0.61-1.07),但仅在 UC 患者中,2014 年结肠切除术显著增加(AOR 2.12,95% CI 1.46-3.06)。

结论

在过去十年中,CD 和 UC 中的 CDI 发病率有所增加。尽管 UC 中的结肠切除术显著增加,但在此期间,CD 和 UC 中 CDI 相关死亡率并未增加。

相似文献

1
Colectomy Rates Are Increasing Among Inpatients With Concomitant Ulcerative Colitis and Clostridioides difficile.同时患有溃疡性结肠炎和艰难梭菌的住院患者的结肠切除术率正在上升。
J Clin Gastroenterol. 2021 Sep 1;55(8):709-715. doi: 10.1097/MCG.0000000000001412.
2
Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease.炎症性肠病住院患者中艰难梭菌感染的相关近期趋势和危险因素。
Aliment Pharmacol Ther. 2024 Jan;59(1):89-99. doi: 10.1111/apt.17777. Epub 2023 Oct 24.
3
Obesity Is Associated with Increased Risk of Colectomy in Inflammatory Bowel Disease Patients Hospitalized with Clostridium difficile Infection.肥胖与艰难梭菌感染住院的炎症性肠病患者接受结肠切除术的风险增加相关。
Dig Dis Sci. 2019 Jun;64(6):1632-1639. doi: 10.1007/s10620-018-5423-7. Epub 2018 Dec 19.
4
Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease.用于治疗炎症性肠病住院患者艰难梭菌感染的抗生素
Antimicrob Agents Chemother. 2014 Sep;58(9):5054-9. doi: 10.1128/AAC.02606-13. Epub 2014 Jun 9.
5
High incidence and morbidity of Clostridium difficile infection among hospitalized patients with inflammatory bowel disease: A prospective observational cohort study.住院炎症性肠病患者中产艰难梭菌感染的发病率和发病率高:一项前瞻性观察性队列研究。
J Dig Dis. 2019 Sep;20(9):460-466. doi: 10.1111/1751-2980.12798.
6
Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis.艰难梭菌感染与溃疡性结肠炎患者的长期预后较差相关。
J Crohns Colitis. 2012 Apr;6(3):330-6. doi: 10.1016/j.crohns.2011.09.005. Epub 2011 Oct 22.
7
Impact of Clostridium difficile infection in patients with ulcerative colitis.艰难梭菌感染对溃疡性结肠炎患者的影响。
J Crohns Colitis. 2011 Feb;5(1):34-40. doi: 10.1016/j.crohns.2010.09.007. Epub 2010 Oct 30.
8
The Prevalence and Risk Factors of Infection in Inflammatory Bowel Disease: 10-Year South Korean Experience Based on the National Database.炎症性肠病感染的患病率和危险因素:基于全国数据库的韩国 10 年经验。
J Korean Med Sci. 2023 Dec 4;38(47):e359. doi: 10.3346/jkms.2023.38.e359.
9
P074 Comparative Risk of Clostridioides Difficile Infection in Vedolizumab vs anti-TNFa Agents in Biologic-Naïve Patients With Ulcerative Colitis.P074:在初治的溃疡性结肠炎患者中,维多珠单抗与抗TNFα药物相比,艰难梭菌感染的比较风险
Am J Gastroenterol. 2021 Dec 1;116(Suppl 1):S19. doi: 10.14309/01.ajg.0000798896.93843.63.
10
Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.艰难梭菌感染与不良结局的炎症性肠病患者的病例对照研究,以及艰难梭菌与巨细胞病毒合并感染患者的研究。
Dig Dis Sci. 2018 Nov;63(11):3074-3083. doi: 10.1007/s10620-018-5230-1. Epub 2018 Aug 9.

引用本文的文献

1
The impact of gut microbiome enterotypes on ulcerative colitis: identifying key bacterial species and revealing species co-occurrence networks using machine learning.肠道微生物组 enterotypes 对溃疡性结肠炎的影响:使用机器学习识别关键细菌物种并揭示物种共存网络。
Gut Microbes. 2024 Jan-Dec;16(1):2292254. doi: 10.1080/19490976.2023.2292254. Epub 2023 Dec 20.
2
Early Flexible Sigmoidoscopy Improves Clinical Outcomes in Acute Severe Ulcerative Colitis.早期柔性乙状结肠镜检查可改善急性重度溃疡性结肠炎的临床结局。
Crohns Colitis 360. 2023 May 31;5(3):otad032. doi: 10.1093/crocol/otad032. eCollection 2023 Jul.
3
Risk of Gastrointestinal Infections After Initiating Vedolizumab and Anti-TNFα Agents for Ulcerative Colitis.
溃疡性结肠炎患者起始使用维得利珠单抗和抗 TNFα 药物后发生胃肠道感染的风险。
J Clin Gastroenterol. 2023 Aug 1;57(7):714-720. doi: 10.1097/MCG.0000000000001733.
4
Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease.艰难梭菌感染患者的诊断与管理。
Curr Opin Gastroenterol. 2021 Jul 1;37(4):336-343. doi: 10.1097/MOG.0000000000000739.